<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-6094</journal-id>
<journal-title><![CDATA[Sanus]]></journal-title>
<abbrev-journal-title><![CDATA[Sanus]]></abbrev-journal-title>
<issn>2448-6094</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Sonora, División de Ciencias Biológicas y de la Salud, Departamento de enfermería]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-60942024000100108</article-id>
<article-id pub-id-type="doi">10.36789/sanusrevenf..vi20.472</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectos secundarios post vacunación COVID-19 en población zacatecana]]></article-title>
<article-title xml:lang="pt"><![CDATA[Efeitos colaterais da COVID-19 pós-vacinação na população Zacatecana]]></article-title>
<article-title xml:lang="en"><![CDATA[Post-vaccination COVID-19 side effects in the Zacatecas population]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zorrilla-Martínez]]></surname>
<given-names><![CDATA[Laura Berenice]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flores-Romo]]></surname>
<given-names><![CDATA[Ana Gabriela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Araujo-Espino]]></surname>
<given-names><![CDATA[Roxana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Trejo-Ortiz]]></surname>
<given-names><![CDATA[Perla María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma de Zacatecas Unidad Académica de Enfermería ]]></institution>
<addr-line><![CDATA[ Zacatecas]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Zacatecas Unidad Académica de Enfermería ]]></institution>
<addr-line><![CDATA[ Zacatecas]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Autónoma de Zacatecas Unidad Académica de Enfermería ]]></institution>
<addr-line><![CDATA[ Zacatecas]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Autónoma de Zacatecas Unidad Académica de Enfermería ]]></institution>
<addr-line><![CDATA[ Zacatecas]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>9</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-60942024000100108&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-60942024000100108&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-60942024000100108&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: La COVID-19 es una patología que puede ser mortal, la vacunación ha demostrado ser eficaz para reducir la mortalidad, pudiesen presentarse efectos secundarios, la gestión y administración de vacunas por personal de enfermería ha sido fundamental para disminuir la presencia de casos graves.  Objetivo:  Comparar los efectos secundarios presentados en la primera y segunda dosis de vacunas COVID-19 por características sociodemográficas en población zacatecana.  Metodología:  Estudio descriptivo, comparativo, en 366 adultos zacatecanos seleccionados por muestreo no probabilístico, mayores de edad, que contaban con dos dosis de vacuna anticovid-19, se excluyeron a quienes no contaran con cartilla nacional de salud o comprobante de vacunación, se aplicó Ficha técnica de Efectos adversos post-vacunación COVID-19; los efectos adversos se consideraron como una respuesta no deseada posterior vacunación. Los sujetos de estudio participaron de manera voluntaria, anónima y se obtuvo firma previa de consentimiento informado. Los datos se analizaron mediante estadística descriptiva y pruebas no paramétricas.  Resultados:  La mayoría fueron mujeres, con 2 dosis de vacuna, 45.9 % se aplicó vacuna Pfizer, 68.6 % presentó COVID-19 antes de ser vacunado, hubo mayores efectos secundarios en el grupo de 18 a 30 años, no hubo diferencias estadísticas significativas por escolaridad, estado civil, nivel socioeconómico y lugar de residencia, en primera y segunda dosis las vacunas AstraZeneca, Cansino y Moderna presentaron mayor efecto secundario que Pfizer.  Conclusiones:  El presente estudio coincide con investigaciones realizadas donde los efectos secundarios fueron menores en la segunda dosis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Abstrato  Introdução: A COVID-19 é uma patologia que pode ser fatal; a vacinação tem se mostrado eficaz na redução da mortalidade, efeitos colaterais podem ocorrer, o manejo e administração de vacinas pela equipe de enfermagem tem sido essencial para reduzir a presença de casos graves.  Objetivo: Comparar os efeitos colaterais apresentados na primeira e segunda doses de vacinas COVID-19 por características sociodemográficas na população Zacatecas.  Metodologia:  estudo descritivo, comparativo, em 366 adultos Zacatecanos selecionados por amostragem não probabilística, maiores de idade, que receberam duas doses da vacina anticovid-19, excluídos aqueles que não possuíam cartão nacional de saúde ou comprovante de vacinação, aplicou-se a Ficha Técnica de Efeitos Adversos pós-vacinação COVID-19; Efeitos adversos foram considerados como uma resposta indesejada após a vacinação. Os sujeitos do estudo participaram de forma voluntária, anônima e obtiveram assinatura prévia do termo de consentimento livre e esclarecido. Os dados foram analisados por meio de estatística descritiva e testes não paramétricos.  Resultados:  A maioria eram mulheres, com 2 doses da vacina, 45,9 % foram vacinados Pfizer, 68,6 % tiveram COVID-19 antes de serem vacinados, houve maiores efeitos colaterais no grupo de 18 a 30 anos, não houve diferenças estatisticamente significativas por escolaridade, estado civil, nível socioeconômico e local de residência, na primeira e segunda doses das vacinas da AstraZeneca, Cansino e Moderna tiveram mais efeitos colaterais do que a Pfizer.  Conclusões:  O presente estudo coincide com a pesquisa conduzida onde os efeitos colaterais foram menores na segunda dose. O presente estudo reafirma que a pesquisa conduzida sobre os efeitos colaterais das vacinas COVID-19.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  COVID-19 is a pathology that can be fatal; vaccination has been shown to be effective in reducing mortality, side effects may occur, the management and administration of vaccines by nursing personnel has been essential to reduce the presence of severe cases.  Objective:  To compare the side effects presented in the first and second doses of COVID-19 vaccines by sociodemographic characteristics in the Zacatecas population.  Methodology:  descriptive, comparative study, in 366 Zacatecas adults selected by non-probabilistic sampling, of legal age, who had two doses of anticovid-19 vaccine, those who did not have a national health card or proof of vaccination were excluded, the Technical Sheet of Adverse Effects post-vaccination COVID-19 was applied; Adverse effects were considered as an unwanted response following vaccination. The study subjects participated voluntarily, anonymously and obtained prior signature of informed consent. Data were analyzed using descriptive statistics and non-parametric tests.  Results:  The majority were women, with 2 doses of vaccine, 45.9 % were vaccinated Pfizer, 68.6 % had COVID-19 before being vaccinated, there were greater side effects in the group of 18 to 30 years, there were no statistically significant differences by education, marital status, socioeconomic level and place of residence, in the first and second doses of the AstraZeneca vaccines, Cansino and Moderna had more side effects than Pfizer.  Conclusions:  The present study coincides with research conducted where side effects were lower at the second dose. The present study reaffirms that research conducted on the side effects of COVID-19 vaccines.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Efecto Secundario]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[Vacunas (DeCS)]]></kwd>
<kwd lng="pt"><![CDATA[Efeito colateral]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[Vacinas (DeCS)]]></kwd>
<kwd lng="en"><![CDATA[After effect]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Vaccines (DeCS)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Castrillón]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Toro-Montoya]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SARS-CoV-2/COVID-19: El virus, la enfermedad y la pandemia]]></article-title>
<source><![CDATA[Med. Lab]]></source>
<year>2020</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>183-205</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cadena-Estrada]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Olvera-Arreola]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[López-Flores]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Hernández]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lira-Rodríguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Cisneros]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermería ante el COVID-19, un punto clave para la prevención, control y mitigación de la pandemia]]></article-title>
<source><![CDATA[Arch. Cardiol. Méx]]></source>
<year>2020</year>
<volume>90</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>94-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chuquimarca-Pardo]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rol del profesional de enfermería durante la vacunación contra el COVID-19]]></article-title>
<source><![CDATA[LATAM]]></source>
<year>2023</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4363-73</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaparro-Mérida]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Samper]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Lacato]]></surname>
<given-names><![CDATA[AO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguridad de las vacunas contra la COVID-19]]></article-title>
<source><![CDATA[Rev Peru Med Exp Salud Pública]]></source>
<year>2021</year>
<volume>38</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>634-42</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vacunas contra el Covid-19]]></article-title>
<source><![CDATA[Centros para el Control y la Prevención de Enfermedades]]></source>
<year>2022</year>
<publisher-name><![CDATA[Estados Unidos: Centro Nacional de Vacunación y Enfermedades Respiratorias]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabezas-Sánchez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19: La vacunación como una de las esenciales estrategias para su control]]></article-title>
<source><![CDATA[An. Fac. Med]]></source>
<year>2023</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vacunas vs covid-19 (actualización)]]></article-title>
<source><![CDATA[Centro de Investigación y de Estudios Avanzados]]></source>
<year>2021</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Gobierno de México]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud (OMS)</collab>
<article-title xml:lang=""><![CDATA[La OMS publica su primera validación para uso en emergencias de una vacuna contra la COVID-19 y hace hincapié en la necesidad de un acceso mundial equitativo]]></article-title>
<source><![CDATA[]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortés-López]]></surname>
<given-names><![CDATA[YI]]></given-names>
</name>
<name>
<surname><![CDATA[López-Paz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Marín-Márquez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Albavera-Peña]]></surname>
<given-names><![CDATA[JDD]]></given-names>
</name>
<name>
<surname><![CDATA[Montiel-Jarquín]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Parada-Jiménez]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Panorama clínico del comportamiento de COVID-19 en Puebla: Prevalencia y gravedad]]></article-title>
<source><![CDATA[revmedica]]></source>
<year>2021</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>39-56</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arrúa-Báez]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy-Rolón]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Galeano-Ruiz-Díaz]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos adversos asociados a las vacunas COVID-19 en funcionarios y estudiantes de la Facultad de Ciencias Químicas de la UNA, año 2021. Revisión de literatura]]></article-title>
<source><![CDATA[Rev. Soc. Cient. Parag]]></source>
<year>2023</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>71-83</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguirre-Morales]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Henao]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona-Villa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Santamaria-Salazar]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas asociadas a vacunas contra la COVID-19]]></article-title>
<source><![CDATA[CES Med]]></source>
<year>2021</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>230-43</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Collado]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Castiñeiras-Ortega]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[González-Contreras]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[González-De Abreú]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Casma-López]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez-López]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas notificadas tras la administración de vacuna frente a Covid-19 en trabajadores de un hospital terciario]]></article-title>
<source><![CDATA[Rev Asoc Esp Espec Med Trab]]></source>
<year>2021</year>
<volume>30</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>125-261</page-range><publisher-name><![CDATA[Internet]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Osorno]]></surname>
<given-names><![CDATA[ZR]]></given-names>
</name>
<name>
<surname><![CDATA[Perón-Medina]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Velázquez]]></surname>
<given-names><![CDATA[IO]]></given-names>
</name>
<name>
<surname><![CDATA[Morales-Fernández]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Mosqueda]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Vilchis]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacunas contra la COVID-19]]></article-title>
<source><![CDATA[Acta méd. Grupo Ángeles]]></source>
<year>2021</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>429-44</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Rojas]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Almonacid-Urrego]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha-Chamorro]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo-Pretelt]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo]]></article-title>
<source><![CDATA[NOVA]]></source>
<year>2020</year>
<volume>18</volume>
<numero>35</numero>
<issue>35</issue>
<page-range>65-72</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ríos-González]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Mendez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Estigarribia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos secundarios de las vacunas anti-COVID-19 en personal de salud de Paraguay: estudio exploratorio]]></article-title>
<source><![CDATA[Rev. Salud Pública Parag]]></source>
<year>2023</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>24-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Balbuena]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Samudio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas post vacunación, y eventual infección por Covid-19 en odontólogos]]></article-title>
<source><![CDATA[Rev. cient cienc. Salud]]></source>
<year>2021</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-94</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castelo-Rivas]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
<name>
<surname><![CDATA[Carrión-Cevallos]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Cedeño]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tipanluisa-Cajilema]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas de vacunados contra la COVID-19 pertenecientes al Recinto Umpechico, Ecuador]]></article-title>
<source><![CDATA[Rev Inf Cient]]></source>
<year>2022</year>
<volume>101</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Polit]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Tatano]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
</person-group>
<source><![CDATA[Investigación en enfermería: Fundamentos para el uso de la evidencia en la práctica de la enfermería]]></source>
<year>2018</year>
<edition>9ª ed</edition>
<page-range>119-20</page-range><publisher-name><![CDATA[España]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serrano-Franco]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El consentimiento informado como un continuo narrativo]]></article-title>
<source><![CDATA[Rev Bio y Der]]></source>
<year>2022</year>
<volume>1</volume>
<numero>54</numero>
<issue>54</issue>
<page-range>83-102</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palacios-Cruz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Velázquez-Cervantes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[León-Juárez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19, una emergencia de salud pública mundial]]></article-title>
<source><![CDATA[Rev Clin Esp]]></source>
<year>2020</year>
<volume>221</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>55-61</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud (OMS)</collab>
<article-title xml:lang=""><![CDATA[Eficacia teórica, eficacia real y protección de las vacunas]]></article-title>
<source><![CDATA[]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<collab>Memorial Sloan Kettering Cancer Center (MSKCC)</collab>
<article-title xml:lang=""><![CDATA[Efectividad, efectos secundarios, seguridad y más de la vacuna COVID-19 2023-2024]]></article-title>
<source><![CDATA[]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Estados Unidos de América ]]></publisher-loc>
<publisher-name><![CDATA[MSKCC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud (OMS)</collab>
<article-title xml:lang=""><![CDATA[Evaluación de la eficacia de la vacuna COVID-19: orientaciones provisionales, 17 de marzo de 2021]]></article-title>
<source><![CDATA[]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud (OMS)</collab>
<article-title xml:lang=""><![CDATA[Vacunas contra la COVID-19]]></article-title>
<source><![CDATA[]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<collab>Centro de Investigación y de Estudios Avanzados</collab>
<article-title xml:lang=""><![CDATA[Vacunas vs covid-19 (actualización)]]></article-title>
<source><![CDATA[]]></source>
<year>2021</year>
<publisher-name><![CDATA[Gobierno de México]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
